Therapy of cancer metastasis by activation of the inducible nitric oxide synthase

Cancer and Metastasis Reviews

Volumn 17, Issue 1, 1998, Pages 55-75

  Xie, Keping ^a   Fidler, Isaiah J ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Apoptosis; iNOS; Metastasis; Therapy

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ARTICLE; CANCER INHIBITION; CANCER THERAPY; ENZYME ACTIVATION; ENZYME INDUCTION; EXPRESSION VECTOR; GENE TARGETING; GENE THERAPY; GROWTH INHIBITION; METASTASIS; METASTASIS INHIBITION; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL;

ANIMALS; ENZYME ACTIVATION; ENZYME INDUCTION; HUMANS; MICE; NEOPLASM METASTASIS; NEOPLASMS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II;

EID: 0031949941     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005956721457     Document Type: Article

References (210)

1. Fidler IJ: Critical factors in the biology of human cancer metastasis: Twenty-eighth G.H.A. Clowes Memorial Award Lecture. Cancer Res 50: 6130-6138, 1990
2. Willis RA: The Spread of Tumors in the Human Body. Butterworth, London, 1972
3. Sugarbaker EV: Cancer metastasis: a product of tumor-host interactions. Curr Probl Cancer 3: 1-59, 1979
4. Weiss L: Principles of Metastasis. Academic Press, Orlando, 1985
5. Fidler IJ, Balch CM: The biology of cancer metastasis and implications for therapy. Curr Probl Surg 24: 137-209, 1987
6. Jain RK: Barriers to drug delivery in solid tumors. Scientific American 271: 58-65, 1994
7. Fidler IJ: Modulation of the organ microenvironment for the treatment of cancer metastasis (Editorial). J Natl Cancer Inst 84: 1588-1592, 1995
8. Price JE, Aukerman SL, Fidler IJ: Evidence that the process of murine melanoma metastasis is sequential and selective and contains stochastic elements. Cancer Res 46: 5172-5178, 1986
9. Aukerman SL, Price JE, Fidler IJ: Different deficiencies in the prevention of tumorigenic-low metastatic murine K-1735 melanoma cells from producing metastases. J Natl Cancer Inst 77: 915-924, 1986
10. Folkman J: Endothelial cells and angiogenic growth factors in cancer growth and metastasis (Introduction). Cancer Metastasis Rev 9: 171-174, 1990
11. Folkman J, Taylor K: Tumor angiogenesis: Its possible role in metastasis and invasion. In: Day SB, Myers WPL, Stansly P, Gerattini S, Lewis MG (eds) Cancer Invasion and Metastasis: Biologic Mechanisms and Therapy. Raven Press, New York, 1977, pp 95-103
12. Fidler IJ, Ellis LM: The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79: 185-188, 1994
13. Leek RD, Harris AL, Lewis CE: Cytokine networks in solid human tumors: regulation of angiogenesis. J Leukocyte Biol 56: 423-435, 1994
14. Liotta LA, Kleinerman J, Saidel GM: Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res 34: 997-1004, 1974
15. Liotta LA, Stetler-Stevenson WG: Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 51: 5054s-5059s, 1991
16. Gasic GJ: Role of plasma, platelets and endothelial cells in tumor metastasis. Cancer Metastasis Rev 3:99-105, 1984
17. Fidler IJ, Bucana C: Mechanism of tumor cell resistance to lysis by syngeneic lymphocytes. Cancer Res 37: 3945-3956, 1977
18. Weiss L: Biomechanical interactions of cancer cells with the microvasculature during hematogenous metastasis. Cancer Metastasis Rev 11: 227-235, 1992
19. Nicolson GL: Cancer metastasis: tumor cell and host organ properties important in metastasis to specific secondary sites. Biochim Biophys Acta 948: 175-208, 1988
20. Zetter BR: The cellular basis of site-specific tumor metastasis. N Engl J Med 322: 605-612, 1990
21. Hart IR, Saini A: Biology of tumor metastasis. Lancet 339: 1437-1453, 1992
22. Radinsky R: Paracrine growth regulation of human colon carcinoma organ-specific metastasis. Cancer Metastasis Rev 12:345-361, 1993
23. O'Reilly MS, Homgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sago EH, Folkman J: Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79: 315-328, 1994
24. Fidler IJ, Gersten DM, Hart IR: The biology of cancer invasion and metastasis. Adv Cancer Res 28: 149-250, 1978
25. 125I-5-iodo-2′-deoxyuridine. J Natl Cancer Inst 45: 773-782, 1970
26. Glaves D: Intravascular death of disseminated cancer cells mediated by superoxide anion. Invasion Metastasis 6: 101-111, 1986
27. Fidler IJ, Kripke ML: Metastasis results from preexisting variant cells within a malignant tumor. Science 197: 893-895, 1977
28. Talmadge JE, Fidler IJ: Enhanced metastatic potential of tumor cells harvested from spontaneous metastases of heterogeneous murine tumors. J Natl Canter Inst 69: 975-980, 1982
29. Fidler IJ, Talmadge JE: Evidence that intravenously derived murine pulmonary melanoma metastases can originate from the expansion of a single tumor cell. Cancer Res 46: 5167-5171, 1986
30. Sato H, Suzuki M: Deformability and viability of tumor cells by transcapillary passage with reference to organ affinity in metastasis in cancer. In: Weiss L (ed) Fundamental Aspects of Metastasis. North-Holland, Amsterdam, 1976, pp 311-317
31. Fidler IJ: The relationship of embolic homogeneity, number, size and viability to the incidence of experimental metastasis. Eur J Cancer 9: 223-227, 1973
32. Liotta LA, Kleinerman J, Seidel GM: The significance of hematogenous tumor cell clumps in the metastatic process. Cancer Res 36: 889-894, 1976
33. Hofmann M, Rudy W, Zoller M, Tolg C, Ponta H, Jerrlich P, Gunthert U: CD44 splice variants confer metastatic behavior in rats: Homologous sequences are expressed in human tumor cell lines. Cancer Res 51: 5292-5297, 1991
34. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Lochner D, Birchmeier V: E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 13: 173-185, 1991
35. Karpatkin S, Pearlstein E: Role of platelets in tumor cell metastasis. Ann Intern Med 95: 636-674, 1981
36. Wiltrout RH, Frost P, Morrison MK, Kerbel RS: Immune-mediated arrest and reversal of established visceral metastasis in athymic mice. Cancer Res 39: 4034-4039, 1979
37. Hanna N, Fidler IJ: The role of natural killer cells in the destruction of circulating tumor emboli. J Natl Cancer Inst 65: 801-809, 1980
38. Herberman RB: Natural killer cells. Prog Clin Biol Res 288: 161-167, 1989
39. Fidler IJ: Macrophages and metastasis - a biological approach to cancer therapy: Presidential address. Cancer Res 45: 4714-4721, 1985
40. Li L, Nicolson GL, Fidler IJ: Direct in vitro lysis of metastatic tumor cells by cytokine-activated murine vascular endothelial cells. Cancer Res 51: 245-254, 1991
41. Li L, Kilbourn RG, Adams J, Fidler IJ: Role of nitric oxide in lysis of tumor cells by cytokine-activated endothelial cells. Cancer Res 51: 2531-2535, 1991
42. Dong Z, O'Brian CA, Fidler IJ: Activation of tumoricidal properties in macrophages by lipopolysaccharide requires protein-tyrosine kinase activity. J Leukocyte Biol 53: 53-60, 1993
43. Poste G, Fidler IJ: The pathogenesis of cancer metastasis. Nature 283: 139-146, 1979
44. Fidler IJ, Gruys E, Cifone MA, Barnes Z, Bucana CD: Demonstration of multiple phenotypic diversity in a murine melanoma of recent origin. J Natl Cancer Inst 67: 947-956, 1981
45. Xie K, Dong Z, Fidler IJ: Activation of nitric oxide synthase gene for inhibition of cancer metastasis (Review). J Leukocyte Biol 59: 797-803, 1996
46. Radomski MK, Jenkins DC, Jolmes L, Moncada S: Human colorectal adenocarcinoma cells: differential nitric oxide synthesis determines their ability to aggregate platelets. Cancer Res 51: 6073-6077, 1991
47. Palmer RMJ, Ferrige AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelial-derived relaxing factor. Nature 327: 524-526, 1987
48. Hibbs JR JB, Taintor RR, Vavrin Z: Macrophage cytotoxicity: role for L-arginine deiminase activity and amino nitrogen to nitrate. Science 235: 473-476, 1987
49. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G: Endothelial-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84: 9265-9269, 1987
50. Nathan C: Nitric oxide as a secrelory product of mammalian cells. FASEB J 6: 3051-3064, 1992
51. Nathan C, Xie Q-W: Nitric oxide synthases: roles, tolls, and controls. Cell 78: 915-919, 1994
52. Jaffrey SR, Snyder SH: Nitric oxide: a neural messenger. Annu Rev Cell Dev Biol 11: 417-440, 1995
53. Marletta MA: Nitric oxide synthase structure and mechanism. J Biol Chem 268: 12231-12234, 1993
54. G-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun 172: 1132-1138, 1991
55. Kamijo R, Harada H, Matsuyama T, Bosland M, Gerecitano J, Shapiro D, Le J, Koh SI, Kimura T, Green SJ et al.: All authors required: Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 263: 1612-1615, 1994
56. Martin E, Nathan C, Xie QW: Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J Exp Med 180: 977-984, 1994
57. Xie QW, Kashiwabara Y, Nathan C: Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem 269: 4705-4708, 1994
58. Adcock IM, Brown CR, Kwon O, Barnes PJ: Oxidative stress induces NF kappa B DNA binding and inducible NOS mRNA in human epithelial cells. Biochem Biophys Res Commun 199: 1518-1524, 1994
59. Vodovotz Y, Bogdan C, Paik J, Xie QW, Nathan C: Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta. J Exp Med 178: 605-613, 1993
60. Kolyada AY, Savikovsky N, Madias NE: Transcriptional regulation of the human iNOS gene in vascular-smooth-muscle cells and macrophages: evidence for tissue specificity. Biochem Biophys Res Commun 220: 600-605, 1996
61. Albina JE: On the expression of nitric oxide synthase by human macrophages. Why no NO? J Leukocyte Biol 58: 643-649, 1995
62. Lee SC, Dickson DW, Brosnan CF, Casadevall A: Human astrocytes inhibit Cryptococcus neoformans growth by a nitric oxide-mediated mechanism. J Exp Med 180: 3695-3699, 1994
63. Kasai K, Hattari Y, Nakanishi N, Manaka K, Banba N, Motohashi S, Shimoda S: Regulation of inducible nitric oxide production by cytokines in human thymocytes in culture. Endocrinology 136: 4261-4270, 1995
64. Nussler AK, Di Silvio M, Billiar TR, Hoffman RA, Geller DA, Selby R, Madariaga J, Simmons RL: Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J Exp Med 176: 261-264, 1992
65. Nicholson S, Bonecini-Almeida M, da G Lapa e Silva JR, Nathan C, Xie QW, Mumford R, Weidner JR, Calaycay J, Geng J, Boechat N, Linhares C, Rom W, Ho JL: Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J Exp Med 183: 2293-2302, 1996
66. Evans TJ, Buttery LD, Carpenter A, Springall DR, Polak JM, Cohen J: Cytokine-treated human neutrophils contain inducible nitric oxide synthase that produces nitration of ingested bacteria. Proc Natl Acad Sci USA 93: 9553-9558, 1996
67. Park CS, Pardhasaradhi K, Gianotti C, Villegas E, Krishna G: Human retina expresses both constitutive and inducible isol'orms of nitric oxide synthase mRNA. Biochem Biophys Res Commun 205: 85-91, 1994
68. Sirsjo A, Karlsson M, Gidlof A, Rollman O, Torma H: Increased expression of inducible nitric oxide synthase in psoriatic skin and cytokine-stimulated cultured keratonocytes. Br J Dermatol 134: 643-648, 1996
69. Kolios G, Brown Z, Robson RL, Robertson DA, Westwick J: Inducible nitric oxide synthase activity and expression in a human colonic epithelial cell line. HT-29. Br J Pharmacol 116: 2866-2872, 1995
70. Wang R, Ghahary A, Shen YJ, Scott PG, Tredget EE: Human dermal fibroblasts produce nitric oxide and express both constitutive and inducible nitric oxide synthase isoforms. J Invest Dermatol 106: 419-427, 1996
71. Furukawa K, Harrison DG, Saleh D, Shennib H, Chagnon FP, Giaid A: Expression of nitric oxide synthase in the human nasal mucosa. Am J Resp Crit Care Med 153: 847-850, 1996
72. Mehta JL, Chen LY, Kone BC, Mehta P, Turner P: Identification of constitutive and inducible forms of nitric oxide synthase in human platelets. J Lab Clin Med 125: 370-377, 1995
73. Asano K, Chee CB, Gaston B, Lilly CM, Gerard C, Drazen JM, Stamler JS: Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells. Proc Natl Acad Sci USA 91: 10089-10093, 1994
74. Palmer RM, Hickery MS, Charles IG, Moncada S, Bayliss MT: Induction of nitric oxide synthase in human chondrocytes. Biochem Biophys Res Commun 193: 398-405, 1993
75. Berrazueta JR, Salas E, Amado JA, Sanchez de Vega MJ, Poveda JJ: Induction of nitric oxide synthase in human mammary arteries in vitro. Eur J Pharmacol 251: 303-305, 1994
76. Nicolson AG, Haites NE, McKay NG, Wilson HM, Macleod AM, Benjamin N: Induction of nitric oxide synthase in human mesangial cells. Biochem Biophys Res Commun 193: 1269-1274, 1993
77. Lelchuk R, Radomski MW, Martin JF, Moncada S: Constitutive and inducible nitric oxide synthases in human megakaryoblastic cells. J Pharmacol Exp Ther 262: 1220-1224, 1992
78. Thoenes M, Forstermann U, Tracey WR, Bleese NM, Nussler AK, Scholz H, Stein B: Expression of inducible nitric oxide synthase in failing and non-failing human heart. J Mol Cell Cardiol 28: 165-169, 1996
79. Buttery LD, Springall DR, Chester AH, Evans TJ, Standfield EN, Parums DV, Yacoub MH, Polak JM: Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest 75: 77-85, 1996
80. Lewis NP, Tsao PS, Rickenbacher PR, Xue C, Johns RA, Haywood GA, von der Leyen H, Trindade PT, Cooke JP, Hunt SA, Billingham ME, Valantine HA, Fowler MB: Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle. Circulation 93: 720-729, 1996
81. Schonfelder G, John M, Hopp H, Fuhr N, van der Giet M, Paul M: Expression of inducible nitric oxide synthase in placenta of women with gestational diabetes. FASEB J 10: 777-784, 1996
82. Sakurai H, Kohsaka H, Liu MF, Higashiyama H, Hirata Y, Kanno K, Saito I, Miyasaka N: Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J Clin Invest 96: 2357-2363, 1995
83. Bo L, Dawson TM, Wesselingh S, Mork S, Choi S, Kong PA, Hanley D, Trapp BD: Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann Neurol 36: 778-786, 1994
84. Tracey WR, Xue C, Klinghofer V, Barlow J, Pollock JS, Forstermann U, Johns RA: Immunochemical detection of inducible NO synthase in human lung. Am J Physiol 266: L722-L727, 1994
85. Ellie E, Loiseau H, Lafond F, Arsaul J, Demotes-Mainard J: Differential expression of inducible nitric oxide synthase mRNA in human brain tumours. Neuroreport 7: 294-296, 1995
86. Hokari A, Zeniya M, Esumi H: Cloning and functional expression of human inducible nitric oxide synthase (NOS) cDNA from a glioblastoma cell line A-172. J Biochem 116: 575-581, 1994
87. Moochhala S, Chhatwall VJ, Chan ST, Ngoi SS, Chia YW, Rauff A: Nitric oxide synthase activity and expression in human colorectal cancer. Carcinogenesis 17: 1171-1174, 1996
88. Jenkins DC, Charles IG, Baylis SA, Lelchuk R, Radomski MW, Moncada S: Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene expression and nitric oxide generation. Br J Cancer 70: 847-849, 1994
89. Sherman PA, Laubach VE, Reep BR, Wood ER: Purification and cDNA sequence of an inducible nitric oxide synthase from a human tumor cell line. Biochemistry 32: 11600-11605, 1993
90. Rosbe KW, Prazma J, Petrusz P, Mims W, Ball SS, Weissler MC: Immunohistochemical characterization of nitric oxide synthase activity in squamous cell carcinoma of the head and neck. Otolaryngology - Heck Neck Surg 113: 541-549, 1995
91. Thomsen LL, Miles DW, Happerfield L, Bobrow LG, Knowles RG, Moncada S: Nitric oxide synthase activity in human breast cancer. Br J Cancer 72: 41-44, 1995
92. Zhang X, Laubach VE, Alley EW, Edwards KA, Sherman PA, Russell SW, Murphy WJ: Transcriptional basis for hyporesponsiveness of the human inducible nitric oxide synthase gene to lipopolysaccharide/interferon-gamma. J Leukocyte Biol 59: 575-585, 1996
93. Tzeng E, Yoneyama T, Hatakeyama K, Shears LL II, Billiar TR: Vascular inducible nitric oxide synthase gene therapy: requirement for guanosine triphosphate cyclohydrolase I. Surgery 120: 315-321, 1996
94. Rocha M, Kruger A, Van Rooijen N, Schirrmacher V, Umansky V: Liver endothelial cells participate in T-cell-dependent host resistance to lymphoma metastasis by production of nitric oxide in vivo. Int J Cancer 63: 405-411, 1995
95. Farias-Eisner R, Sherman MP, Aeberhard E, Chaudhuri G: Nitric oxide is an important mediator for tumoricidal activity in vivo. Proc Natl Acad Sci USA 91: 9407-9411, 1994
96. G-nitro-L-arginine and/or L-arginine on experimental pulmonary metastasis in mice. Cancer Lett 87: 115-120, 1994
97. Pipili-Synetos E, Papageorgiou A, Sakkoula E, Sotiropoulou G, Fotsis T, Karakiulakis G, Maragoudakis ME: Inhibition of angiogenesis, tumor growth and metastasis by the NO-releasing vasodilators, isosorbide mononitrate and dinitrate. Brit J Pharmacol 116: 1829-1834, 1995
98. Xie K, Wang Y, Huang S, Xu L, Bielenberg D, Salas T, McConkey DJ, Jiang W, Fidler IJ: Nitric oxide-mediated apoptosis of K-1735 murine melanoma cells is associated with down-regulation of Bcl-2. Oncogene, in press, 1997
99. Murata J, Corradin SB, Janzer RC, Juillerat-Jeanneret L: Tumor cells suppress cytokine-mediated nitric-oxide (NO) production in cerebral endothelial cells. Int J Cancer 59: 699-705, 1994
100. Denhardt DT, Chambers AF: Overcoming obstacles to metastasis - defenses against host defenses: osteopontin (OPN) as a shield against attack by cytotoxic host cells (Review). J Cell Biochem 56: 48-51, 1994
101. Kripke ML: Speculations on the role of ultraviolet radiation in the development of malignant melanoma. J Natl Cancer Inst 63: 541-545, 1979
102. Staroselsky AH, Pathak S, Chernajovsky Y, Tucker SI, Fidler IJ: Predominance of the metastatic phenotype in somatic cell hybrids of the K-1735 murine melanoma. Cancer Res 51: 6292-6297, 1991
103. Dong Z, Staroselsky AH, Qi X, Xie K, Fidler IJ: Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K-1735 murine melanoma cells. Cancer Res 54: 789-793, 1994
104. Radomski MW, Palmer RMJ, Moncada S: An L-arginine/ nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA 87: 5193-5197, 1990
105. Tsuruo T, Kawabata H, Iida H, Yomori T: Tumor-induced platelet aggregation and growth promoting factors as determinants for successful tumor metastasis. Clin Exp Metastasis 7: 25-29, 1986
106. De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone MA Jr, Shin WS, Liao JK: Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 96: 60-68, 1995
107. Shin WS, Hong YH, Peng HB, De Caterina R, Libby P, Liao JK: Nitric oxide attenuates vascular smooth muscle cell activation by interferon-gamma. The role of constitutive NF-κB activity. J Biol Chem 271: 11317-11324, 1996
108. Korbut R, Gryglewski RJ: Nitric oxide from polymorphonuclear leukocytes modulates red blood cell deformability in vitro. Eur J Pharmacol 234: 17-22, 1993
109. Sakkoula E, Haralabopoulos G, Andriopoulou P, Magoudakis ME: Evidence that nitric oxide is an endogenous antiangiogenic mediator. Br J Pharmacol 111: 894-902, 1994
110. Perretti M, Szabo C, Thiemermann C: Effect of interleukin-4 and interleukin-10 on leukocyte migration and nitric oxide production in the mouse. Br J Pharmacol 116: 2251-2257, 1995
111. Pipili-Synetos E, Sakkoula E, Maragoudakis ME: Nitric oxide is involved in the regulation of angiogenesis. Br J Pharmacol 108: 855-857, 1993
112. Xie K, Fidler IJ: Decreased matrix metalloproteinase-2 (MMP-2) expression correlates with suppression of tumorigenicity and metastasis of K-1735 murine melanoma cells transfected with the inducible nitric oxide synthase (iNOS) gene. Proc Am Assoc Cancer Res 38: 1113, 1997
113. Nunokawa Y, Tanaka S: Interferon-gamma inhibits proliferation of rat vascular smooth muscle cells by nitric oxide generation. Biochem Biophys Res Commun 188: 409-415, 1992
114. Sarkar R, Meinberg EG, Stanley JC, Gordon D, Webb RC: Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circulation Res 78: 225-230, 1996
115. Kourembanas S, McQuillan LP, Leung GK, Faller DV: Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J Clin Invest 92: 99-104, 1993
116. Tuder RM, Flook BE, Voelkel NF: Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Fit in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. J Clin Invest 95: 1798-1807, 1995
117. Doi K, Akaike T, Horie H, Noguchi Y, Fujii S, Beppu T, Ogawa M, Maeda H: Excessive production of nitric oxide in rat solid tumor and its implication in rapid tumor growth. Cancer 77: 1598-1604, 1996
118. Ziche M, Morbidelli L, Masini E, Amerini S, Granger HJ, Maggi CA, Geppetti P, Ledda F: Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 94: 2036-2044, 1994
119. Leibovich SJ, Polverini PJ, Fong TW, Harlow LA, Koch CJ: Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism. Proc Natl Acad Sci USA 91: 4190-4194, 1994
120. Fukuo K, Inoue T, Morimoto S, Nakahashi T, Yasuda O, Kitano S, Sasada R, Ogihara T: Nitric oxide mediates cytotoxicity and basic fibroblast growth factor release in cultured vascular smooth muscle cells. A possible mechanism of neovascularization in atherosclerotic plaques. J Clin Invest 95: 669-676, 1995
121. Andrew PJ, Harant H, Lindley IJ: Nitric oxide regulates IL-8 expression in melanoma cells at the transcriptional level. Biochem Biophys Res Commun 214: 949-956, 1995
122. Xie K, Huang S, Dong Z, Juang S-H, Gutman M, Xie Q-W, Nathan C, Fidler IJ: Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis in K-1735 murine melanoma cells. J Exp Med 181: 1333-1343, 1995
123. Xie Q-W, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Ding A, Troso T, Nathan C: Cloning and characterisation of inducible nitric oxide synthase from mouse macrophages. Science 256: 225-228, 1992
124. Karupiah G, Xie Q-W, Mark R, Buller L, Nathan C: Inhibition of viral replication by interferon-γ-induced nitric oxide synthase. Science 261: 1445-1449, 1993
125. Xie K, Fidler IJ: TNF-mediated cytotoxicity in sensitive and resistant L929 fibroblasts correlates with nitric oxide-independent and -dependent mechanisms, respectively (Abstract). J Leukocyte Biol 3: 45, 1992
126. Xie K, Huang S, Dong Z, Fidler IJ: Cytokine-induced apoptosis in transformed murine fibroblasts involves synthesis of endogenous nitric oxide. Int J Oncol 3: 1043-1047, 1993
127. Xie K, Huang S, Dong Z, Gutman M, Fidler IJ: Direct correlation between expression of endogenous inducible nitric oxide synthase and regression of M5076 reticulum cell sarcoma hepatic metastases in mice treated with liposomes containing lipopeptide CGP 31362. Cancer Res 55: 3123-3131, 1995
128. Sarih M, Souvannavong V, Adam A: Nitric oxide synthase induces macrophages death by apoptosis. Biochem Biophys Res Commun 191: 503-508, 1993
129. Albina JE, Cui S, Mateo RB, Reichner JS: Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J Immunol 150: 5080-5085, 1993
130. Kamijo R, Harada H, Matsuyama T, Bosland M, Gerecitano J, Shapiro D, Le J, Im KS, Kimuar T, Green S, Mak TW, Taniguchi T, Vilcek J: Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 263: 1612-1615, 1994
131. Blanco FJ, Ochs RL, Schwarz H, Lotz M: Chondrocyte apoptosis induced by nitric oxide. Am J Pathol 146: 75-85, 1995
132. Campbell IL, Samimi A, Chiang C-S: Expression of the inducible nitric oxide synthase: Correlation with neuropathology and clinical features in mice with lymphocytic choriomeningitis. J Immunol 153: 3622-3629, 1994
133. Cui S, Reichner JS, Mateo RB, Albina JE: Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms. Cancer Res 54: 2462-2467, 1994
134. Fehsel K, Kroncke K-D, Meyer KL, Huber H, Wahn V, Kolb-Bachofen V: Nitric oxide induces apoptosis in murine thymocytes. J Immunol 155: 2858-2865, 1995
135. Kitajima I, Kawahara K, Nakajima T, Soejima Y, Matsuyama T, Maruyama I: Nitric oxide-mediated apoptosis in murine mastocytoma. Biochem Biophys Res Commun 204: 244-251, 1995
136. Paul-Eugene N, Kolb JP, Damais C, Dugas B: Heterogenous nitrite production by IL-4-stimulated human monocytes and peripheral blood monocluear cells. Immunol Lett 42: 31-34, 1994
137. Corradin SB, Fasel N, Buchmuller-Rouiller Y, Ransijn A, Smith J, Mauel J: Induction of macrophage nitric oxide production by interferon-gamma and tumor necrosis factor-alpha is enhanced by interleukin-10. Eur J Immunol 23: 2045-2048, 1993
138. Waldburger KE, Hastings RC, Schaub RG, Goldman SJ, Leonard JP: Adoptive transfer of experimental allergic encephalomyelitis after in vitro treatment with recombinant murinc interleukin-12. Preferential expansion of interferon-gamma-producing cells and increased expression of macrophage-associated inducible nitric oxide synthase as immunomodulatory mechanisms. Am J Pathol 148: 375-382, 1996
139. Mustafa SB, Howard KM, Olson MS: Platelet-activating factor augments lipopolysaccharide-induced nitric oxide formation by rat. Kupffer cells. Hepalology 23: 1622-1630, 1996
140. Ding A, Nathan CF, Graycar J, Derynck R, Stuehr DJ, Srimal S: Macrophage deactivation factor and transforming growth factor-β1, -β2, and -β3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-γ. J Immunol 145: 940-947, 1990
141. Beck KF, Mohaupt MG, Sterzel RB: Endothelin-1 inhibits cytokine-stimulated transcription of inducible nitric oxide synthase in glomerular mesangial cells. Kidney Int 48: 1893-1899, 1995
142. Heck DE, Laskin DL, Gardner CR, Laskin JD: Epidermal growth factor suppresses nitric oxide and hydrogen peroxidase production by keratinocytes: Potential role for nitric oxide in the regulation of wound healing. J Biol Chem 267: 21277-21284, 1992
143. Schini VB, Catovsky S, Schray-Utz B, Busse R, Vanhoutte PM: Insulin-like growth factor I inhibits induction of nitric oxide synthase in vascular smooth muscle cells. Circulation Res 74: 24-32, 1994
144. Liew FY, Li Y, Severn A, Millott S, Schmidt J, Salter M, Moncada S: A possible novel pathway of regulation by murine T helper type 21 (Th2) of a Th1 cell activity via the modulation of the induction of nitric oxide synthase on macrophages. Eur J Immunol 2: 2489-2496, 1991
145. Bogdan C, Vodovotz Y, Paik J, Xie QW, Nathan C: Mechanism of suppression of nitric oxide synthase expression by interleukin-4 in primary mouse macrophages. J Leukocyte Biol 55: 227-233, 1994
146. McCall TB, Palmer RMJ, Moncada S: Interleukin-8 inhibits the induction of nitric oxide synthase in rat peritoneal neutrophils. Biochem Biophys Res Commun 186: 680-687, 1992
147. Cuhna FQ, Moncada S, Liew FY: Interleukin-10 inhibits the induction of nitric oxide synthase by interferon-γ in murine macrophages. Biochem Biophys Res Commun 182: 1155-1159, 1992
148. Becherel PA, Le Goff L, Ktorza S, Ouaaz F, Mencia-Huerta JM, Dugas B, Debre P, Mossalayi MD, Arock M: Interleukin-10 inhibits IgE-mediated nitric oxide synthase induction and cytokine synthesis in normal human keratinocytes. Eur J Immunol 25: 2992-2995, 1995
149. Doyle AG, Herbein G, Montaner LJ, Minty AJ, Caput D, Ferrara P, Gordon S: Interleukin-13 alters the activation state of murine macrophages in vitro: Comparison with interleukin-4 and interferon-γ. Eur J Immunol 24: 1441-1445, 1994
150. Melillo G, Musso T, Sica A, Taylor LS, Cox GW, Varesio L: A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J Exp Med 182: 1683-1693, 1995
151. Xie K, Huang S, Dong Z, Juang S-H, Wang Y, Fidler IJ: Destruction of bystander cells by tumor cells transfected with inducible nitric oxide synthase gene. J Natl Cancer Inst 89: 421-427, 1997
152. Pestka S, Langer JA, Zoon KC, Samuel CE: Interferons and their action. Annu Rev Biochem 56: 727-777, 1987
153. Schmidt HHHW, Watter U: NO at work. Cell 78: 919-925, 1994
154. Haddad EK, Duclos AJ, Baines MG: Early embryo loss is associated with local production of nitric oxide by decidual mononuclear cells. J Exp Med 182: 1143-1153, 1995
155. Kaneto H, Fujii J, Seo HG, Suzuki K, Matsuoka T, Nakamura M, Tatsumi H, Yamasaki Y, Kamada T, Taniguchi N: Apoptotic cell death triggered by nitric oxide in pancreatic beta cells. Diabetes 44: 733-738, 1995
156. Dunger A, Augstein P, Schmidt S, Fischer U: Identification of interleukin 1-induced apoptosis in rat islets using in situ specific labelling of fragmented DNA. J Autoimmunity 9: 309-313, 1996
157. Sveinbjornsson B, Olsen R, Seternes OM, Seljelid R: Macrophage cytotoxicity against murine meth A sarcoma involves nitric oxide-mediated apoptosis. Biochem Biophys Res Commun 223: 643-649, 1996
158. Geng YJ, Hellstrand K, Wennmalm A, Hansson GK: Apoptotic death of human leukemic cells induced by vascular cells expressing nitric oxide synthase in response to IFN-γ and TNF-α. Cancer Res 56: 866-874, 1996
159. Filep JG, Baron C, Lachance S, Perreault C, Chan JS: Involvement of nitric oxide in target-cell lysis and DNA fragmentation induced by murine natural killer cells. Blood 87: 5136-5143, 1996
160. Xiao L, Eneroth PH, Qureshi GA: Nitric oxide synthase pathway may mediate human natural killer cell cytotoxicity. Scand J Immunol 42: 505-511, 1995
161. Cifone MG, Festuccia C, Cironi L, Cavallo G, Chessa MA, Pensa V, Tubaro E, Santoni A: Induction of the nitric oxide-synthesizing pathway in fresh and interleukin 2-cultured rat natural killer cells. Cell Immunol 157: 181-194, 1994
162. 2 and nitric oxide-mediated oxidative stress induce apoptosis in rat skeletal muscle myoblasts. J Neuropathol Exp Neurol 55: 36-43, 1996
163. Palluy O, Rigaud M: Nitric oxide induces cultured cortical neuron apoptosis. Neurosci Lett 208: 1-4, 1996
164. Martin-Sanz P, Diaz-Guerra MJ, Casado M, Bosca L: Bacterial lipopolysaccharide antagonizes transforming growth factor beta 1-induced apoptosis in primary cultures of hepatocytes. Hepatology 23: 1200-1207, 1996
165. Fukuo K, Hata S, Suhara T, Nakahashi T, Shinto Y, Tsujimoto Y, Morimoto S, Ogihara T: Nitric oxide induces upregulation of Fas and apoptosis in vascular smooth muscle. Hypertension 27: 823-826, 1996
166. Shimaoka M, Iida T, Ohara A, Taenaka N, Mashimo T, Honda T, Yoshiya I: NOC, a nitric-oxide-releasing compound, induces dose dependent apoptosis in macrophages. Biochem Biophys Res Commun 209: 519-526, 1995
167. Messmer UK, Lapetina EG, Brune B: Nitric oxide-induced apoptosis in RAW264.7 macrophages is antagonized by protein kinase C- and protein kinase A-activating compounds. Mol Pharmacol 47: 757-765, 1995
168. Xia Y, Dawson VL, Dawson TM, Snyder SH, Zweier JL: Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci USA 93: 6770-6774, 1996
169. Ankarcrona M, Dypbukt JM, Brune B, Nicotera P: Interleukin-1β-induced nitric oxide production activates apoptosis in pancreatic RINm5F cells. Exp Cell Res 213: 172-177, 1994
170. Chun SY, Eisenhauer KM, Kubo M, Hsueh AJ: Interleukin-1β suppresses apoptosis in rat ovarian follicles by increasing nitric oxide production. Endocrinology 136: 3120-3127, 1995
171. Mannick JB, Asano K, Izumi K, Kieff E, Stamler JS: Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell 79: 1137-1146, 1994
172. Lin KT, Xue JY, Nomen M, Spur B, Wong PV: Peroxynitrite-induced apoptosis in HL-60 cells. J Biol Chem 270: 16487-16490, 1995
173. Mitrovic B, Ignarro LJ, Vinters HV, Akers MA, Schmid I, Uittenbogaart C, Merrill JE: Nitric oxide induces necrotic but not apoptotic cell death in oligodendrocytes. Neuroscience 65: 531-539, 1995
174. Mackenzie-Graham AJ, Mitrovic B, Smoll A, Merrill JE: Differential sensitivity to nitric oxide in immortalized, cloned murine oligodendrocyte cell lines. Developmental Neurosci 16: 162-171, 1994
175. Bonfoco E, Krainc D, Ankarcrona M, Nicotera P, Lipton SA: Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci USA 92: 7162-7166, 1995
176. Beckman JS: Oxidative damage and tyrosine nitration from peroxynitrite (Review). Chem Res Toxicol 9: 836-844, 1996
177. Estevez AG, Radi R, Barbeito L, Shin JT, Thompson JA, Beckman JS: Peroxynitrite-induced cytotoxicity in PC12 cells: Evidence for an apoptotic
178. Kong SK, Yim MB, Stadtman ER, Chock PB: Peroxynitrite disables the tyrosine phosphorylation regulatory mechanism: Lymphocyte-specific tyrosine kinase fails to phosphorylate nitrated cdc2(6-20)NH2 peptide. Proc Natl Acad Sci USA 93: 3377-3382, 1996
179. Kuo ML, Chau YP, Wang JH, Shiah SG: Inhibitors of poly (ADP-ribose) polymerase block nitric oxide-induced apoptosis but not differentiation in human leukemia HL-60 cells. Biochem Biophys Res Commun 219: 502-508, 1996
180. Szabo C, Zingarelli B, O'Connor M, Salzman AL: DNA strand breakage, activation of poly (ADP-ribose)synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite. Proc Natl Acad Sci USA 93: 1753-1758, 1996
181. Pou S, Nguyen SY, Gladwell T, Rosen GM: Does peroxynitrite generate hydroxyl radical? Biochim Biophys Acta 1244: 62-68, 1995
182. Lizasoain I, Moro MA, Knowles RG, Darley-Usmar V, Moncada S: Nitric oxide and peroxynitrite exert distinct effects on mitochondrial respiration which are differentially blocked by glutathione or glucose. Biochem J 314: 877-880, 1996
183. Walker MW, Kinter MT, Roberts RJ, Spitz DR: Nitric oxide-induced cytotoxicity: involvement of cellular resistance to oxidative stress and the role of glutathione in protection. Pediatric Res 37: 41-49, 1995
184. Hata Y, Ota S, Hiraishi H, Terano A, Ivey KJ: Nitric oxide enhances cytotoxicity of cultured rabbit gastric mucosal cells induced by hydrogen peroxide. Biochim Biophys Acta 1290: 257-260, 1996
185. Ioannidis I, de Groot H: Cytotoxicity of nitric oxide in Fu5 rat hepatoma cells: evidence for cooperative action with hydrogen peroxide. Biochem J 296: 341-345, 1993
186. Wink DA, Cook JA, Pacelli R, Liebmann J, Krishna MC, Mitchell JB: NO protects against cellular damage by reactive oxygen species (Review). Toxicol Lett 82-83: 221-226, 1995
187. Brown GC: Reversible binding and inhibition of catalase by nitric oxide. Eur J Biochem 232: 188-191, 1995
188. Farias-Eisner R, Chaudhuri G, Aeberhard E, Fukuto JM: The chemistry and tumoricidal activity of nitric oxide/ hydrogen peroxide and the implications to cell resistance/ susceptibility. J Biol Chem 271: 6144-6151, 1996
189. Petit JF, Nicaise M, Lepoivre M, Guissani A, Lemaire G: Protection by glutathione against the antiproliferative effects of nitric oxide. Dependence on kinetics of no release. Biochem Pharmacol 52: 205-212, 1996
190. Schwarz MA, Lazo JS, Yalowich JC, Allen WP, Whitmore M, Bergonia HA, Tzeng E, Billiar TR, Robbins PD, Lancaster Jr JR: Metallothionein protects against the cytotoxic and DNA-damaging effects of nitric oxide. Proc Natl Acad Sci USA 92: 4452-4456, 1995
191. Asahi M, Fujii J, Suzuki K, Seo HG, Kuzuya T, Hori M, Tada M, Fujii S, Taniguchi N: Inactivation of glutathione peroxidase by nitric oxide. Implications for cytotoxicity. J Biol Chem 270: 21035-21039, 1995
192. Walker MW, Kinter MT, Roberts RJ, Spitz DR: Nitric oxide-induced cytotoxicity: involvement of cellular resistance to oxidative stress and the role of glutathione in protection. Pediatric Res 37: 41-49, 1995
193. Noronha-Dutra AA, Epperlein MM, Woolf N: Reaction of nitric oxide with hydrogen peroxide to produce potentially cytotoxic singlet oxygen as a model for nitric oxide-mediated killing. FEBS Lett 321: 59-62, 1993
194. Lepoivre M, Chenais B, Yapo A, Lemaire CJ, Thelander L, Tenu J-P: Alterations of ribonucleotide reductasc activity following induction of the nitrite-generating pathway in adenocarcinoma cells. J Biol Chem 265: 14143-14149, 1990
195. Richter C, Schweizer M, Cossarizza A, Franceschi C: Control of apoptosis by the cellular ATP level (Review). FEBS Lett 378: 107-110, 1996
196. Xie K, Huang S, Dong Z, Fidler IJ: Nitric oxide-mediated apoptosis occurs by a decrease in intracellular pH (Abstract). J Leukocyte Biol 5: 126, 1995
197. Richter C, Gogvadze V, Laffranchi R, Schlapbach R, Schweizer M, Suter M, Walter P, Yaffer M: Oxidants in mitochondria: From physiology to diseases. Biochem Biophys Acta 1271: 67-74, 1995
198. 2+ associated with apoptosis. Meth Cell Biol 46: 41-55, 1995
199. Nathan CF: Natural resistance and nitric oxide. Cell 82: 873-876, 1995
200. Nishio E, Fukushima K, Shiozaki M, Watanabe Y: Nitric oxide donor SNAP induces apoptosis in smooth muscle cells through cGMP-independent mechanism. Biochem Biophys Res Commun 221: 163-168, 1996
201. Brune B, Mohr S, Messmer UK: Protein thiol modification and apoptotic cell death as cGMP-independent nitric oxide (NO) signaling pathways. Rev Physiol Biochem Pharmacol 127: 1-30, 1996
202. Ho YS, Wang YJ, Lin JK: Induction of p53 and p21/WAF1/ CIP1 expression by nitric oxide and their association with apoptosis in human cancer cells. Mol Carcinogen 16: 20-31, 1996
203. Xie K, Huang S, Wang Y, Beltran PJ, Juang SH, Dong Z, Reed JC, McDonnell TJ, McConkey DJ, Fidler IJ: Bcl-2 protects cells from cytokine-induced nitric-oxide-dependent apoptosis. Cancer Immunol Immunother 43: 109-115, 1996
204. Albina JE, Martin BA, Henry WL Jr, Louis CA, Reichner JS: B cell lymphoma-2 transfected P815 cells resist reactive nitrogen intermediate-mediated macrophage-dependent cytotoxicity. J Immunol 157: 279-283, 1996
205. Messmer UK, Reed UK, Brune B: Bcl-2 protects macrophages from nitric oxide-induced apoplosis. J Biol Chem 271: 20192-20197, 1996
206. Genaro AM, Hortelano S, Alvarez A, Martinez C, Bosca L: Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels. J Clin Invest 95: 1884-1890, 1995
207. Fidler IJ, Kleinerman ES: Clinical application of phospholipid liposomes containing macrophage activators for therapy of cancer metastasis. Adv Drug Del Rev 13: 325-240, 1994
208. Hart IR, Talmadge JE, Fidler IJ: Metastatic behavior of a murine reticulum cell sarcoma exhibiting organ-specific growth. Cancer Res 41: 1281-1287, 1980
209. Calderon C, Huang ZH, Gage DA, Sotomayor EM, Lopez DM: Isolation of a nitric oxide inhibitor from mammary tumor cells and its characterization as phosphatidylserine. J Exp Med 180: 945-958, 1995
210. Juang S-H, Xie K, Wang Y, Dong Z, Fidler IJ: Suppression of tumorigenicity and metastasis by murine melanoma cells infected with the PLXSN retrovirus carrying the inducible nitric synthase gene. Proc Am Assoc Cancer Res 37: 2328, 1996